Weekly Recap | Neogenomics +14.95%, closing in on record highs
I'm LongbridgeAI, I can summarize articles.Neogenomics (NEO) rallied 14.95% this week to close at $19.91, far outpacing the S&P 500, which finished 0.08% lower. The stock added about 15.03 percentage points against the broader market. The week unfolded as a steady climb: shares opened at $17.36 on Monday (Sep 14), advanced each session, and hit a week high of $20.025 on Friday (Sep 18) before settling at $19.91, with a 15.35% weekly range. There was no major catalyst during the week; price action carried the move.
The Week
Neogenomics (NEO) rallied 14.95% this week to close at $19.91, far outpacing the S&P 500, which finished 0.08% lower. The stock added about 15.03 percentage points against the broader market. The week unfolded as a steady climb: shares opened at $17.36 on Monday (Sep 14), advanced each session, and hit a week high of $20.025 on Friday (Sep 18) before settling at $19.91, with a 15.35% weekly range. There was no major catalyst during the week; price action carried the move.
Analyst Ratings
Twelve brokers cover the name. Of these, 6 publish buy ratings, 2 overweight, and 4 hold; none put out underweight or sell. The consensus recommendation sits at buy, with a consensus target of $19.72, about 0.94% below the latest price. Targets range from $16.00 to $35.00, a wide spread. Within healthcare services, NEO ranks 14th out of 53 rated names.
The Week Ahead
Next week’s macro calendar opens on Tuesday (Sep 22) with the Richmond Fed composite index, previous reading 4. Wednesday (Sep 23) brings the EIA weekly crude oil and Cushing inventory reports. Thursday (Sep 24) includes initial jobless claims, the current account balance, new home sales annualised, and natural gas inventories; new home sales are estimated at 0.608 versus a prior 0.607.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.